Citigroup
CPXX

Citigroup’s CELATOR PHARMACEUTICALS INC. COMMON STOCK CPXX Stock Holding History

Citigroup’s Portfolio CPXX Stock Details CPXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-23,439
Closed -$707K – 7388
2016
Q2 		$707K Buy
23,439
+23,422
+137,776% +$475K ﹤0.01% 3288
2016
Q1 		$0 Buy
+17
New +$56 ﹤0.01% 8063
2015
Q4 		– Sell
-135
Closed – – 8144
2015
Q3 		$0 Buy
+135
New +$300 ﹤0.01% 8103

Citigroup's CPXX Position: Q3 2016 in Review

Citigroup sold out of CELATOR PHARMACEUTICALS INC. COMMON STOCK (CPXX) in Q3 2016, closing a stake of 23,439 shares — an estimated $707K sold.

Citigroup first reported a position in CPXX in Q3 2015 and held it in 3 quarters. The position peaked at $707K in Q2 2016. 0 funds tracked by Wall St. Rank hold CPXX as of Q3 2016.

  • Citigroup reported no remaining CELATOR PHARMACEUTICALS INC. COMMON STOCK position as of Q3 2016 after selling out during the quarter.
  • Citigroup sold 23,439 CELATOR PHARMACEUTICALS INC. COMMON STOCK shares in Q3 2016, an estimated $707K.
  • Citigroup first reported a position in CELATOR PHARMACEUTICALS INC. COMMON STOCK in Q3 2015 and held it in 3 quarters.
  • Citigroup's CELATOR PHARMACEUTICALS INC. COMMON STOCK position peaked at $707K in Q2 2016.
  • 0 funds tracked by Wall St. Rank held CELATOR PHARMACEUTICALS INC. COMMON STOCK as of Q3 2016.

Based on Citigroup's 13F filing for Q3 2016, filed 10 Nov 2016.